Solid tumors are abnormal masses of tissue that do not generally contain cysts or liquid regions. Solid tumors can be benign (not cancerous) or malignant (cancerous). Different types of solid tumors are named for the type of cells that form them. Sarcomas, carcinomas, and lymphomas are examples of solid tumors. A solid tumor is one of the most prevalent causes of death, despite enormous efforts to explore solid tumor biology and developed test for the diagnosis of solid tumors. This report focus on Non-Conventional Testing market. This report contains market size and forecasts of Solid Tumor Non-Conventional Testing in Global, including the following market information: Global Solid Tumor Non-Conventional Testing Market Revenue, 2017-2022, 2023-2028, ($ millions) Global top five companies in 2021 (%) The global Solid Tumor Non-Conventional Testing market was valued at US$ million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028. The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028. Fluorescence in-situ Hybridization (FISH) Segment to Reach $ Million by 2028, with a % CAGR in next six years. The global key manufacturers of Solid Tumor Non-Conventional Testing include Abbott Laboratories, Agilent Technologies, Avant Diagnostics, Inc., Advanced Cell Diagnostics, Inc., Agena Bioscience, Inc., ARUP Laboratories, Bio-Rad Laboratories, Inc., Biocare Medical, LLC. and Caris Life Sciences., etc. In 2021, the global top five players have a share approximately % in terms of revenue. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Solid Tumor Non-Conventional Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Solid Tumor Non-Conventional Testing Market, by Type, 2017-2022, 2023-2028 ($ millions) Global Solid Tumor Non-Conventional Testing Market Segment Percentages, by Type, 2021 (%) Fluorescence in-situ Hybridization (FISH) Immunohistochemistry (IHC) Polymerase Chain Reaction (PCR) Next-generation Sequencing (NGS) Others Global Solid Tumor Non-Conventional Testing Market, by Application, 2017-2022, 2023-2028 ($ millions) Global Solid Tumor Non-Conventional Testing Market Segment Percentages, by Application, 2021 (%) Hospitals Pharmaceutical and Biotechnology Companies Others Global Solid Tumor Non-Conventional Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) Global Solid Tumor Non-Conventional Testing Market Segment Percentages, By Region and Country, 2021 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Solid Tumor Non-Conventional Testing revenues in global market, 2017-2022 (estimated), ($ millions) Key companies Solid Tumor Non-Conventional Testing revenues share in global market, 2021 (%) Further, the report presents profiles of competitors in the market, key players include: Abbott Laboratories Agilent Technologies Avant Diagnostics, Inc. Advanced Cell Diagnostics, Inc. Agena Bioscience, Inc. ARUP Laboratories Bio-Rad Laboratories, Inc. Biocare Medical, LLC. Caris Life Sciences. F. Hoffmann-La Roche Ltd Foundation Medicine Genomic Testing Cooperative Guardant Health HTG Molecular Diagnostics, Inc. Illumina, Inc. Invitae Corporation Invivoscribe, Inc. Johnson & Johnson Laboratory Corporation of America Holdings MedGenome Labs Private Ltd. Myraid Genetics, Inc. Nanjing Geneseeq NanoString NeoGenomics Laboratories Opko Health, Inc. QIAGEN Quest Diagnostics Incorporated. Thermo Fisher Scientific, Inc. VYANTbio.
1 Introduction to Research & Analysis Reports 1.1 Solid Tumor Non-Conventional Testing Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Solid Tumor Non-Conventional Testing Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5
